Shares of PACS Group, Inc. (NYSE:PACS – Get Free Report) have been assigned an average rating of “Buy” from the eight analysts that are covering the stock, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have covered the stock in the last year is $39.88.
Several equities analysts recently commented on the stock. Stephens reduced their target price on shares of PACS Group from $48.00 to $31.00 and set an “overweight” rating on the stock in a report on Monday, November 18th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $40.00 price objective on shares of PACS Group in a research note on Wednesday, November 6th. UBS Group started coverage on PACS Group in a research note on Wednesday, October 9th. They issued a “buy” rating and a $50.00 target price for the company. Oppenheimer raised their price target on PACS Group from $32.00 to $40.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 13th. Finally, Truist Financial lifted their price target on PACS Group from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Monday, October 14th.
View Our Latest Analysis on PACS
Hedge Funds Weigh In On PACS Group
PACS Group Stock Down 0.4 %
Shares of NYSE PACS opened at $16.55 on Friday. PACS Group has a one year low of $16.09 and a one year high of $43.92. The firm’s 50 day simple moving average is $32.49 and its two-hundred day simple moving average is $33.07. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82.
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also
- Five stocks we like better than PACS Group
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a support level?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Financial Services Stocks Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.